岱美股份(603730.SH):全資子公司獲得高新技術企業證書
格隆匯1月27日丨岱美股份(603730.SH)公佈,近日,公司全資子公司舟山市銀岱汽車零部件有限公司(以下簡稱“舟山銀岱”)收到浙江省科學技術廳、浙江省財務廳、國家税務總局浙江省税務局聯合頒發的《高新技術企業證書》。
舟山銀岱本次取得高新技術企業證書系原高新技術企業證書有效期滿後再次獲得國家高新技術企業認定的結果。根據《中華人民共和國企業所得税法》及其實施條例、《高新技術企業認定管理辦法》等有關規定,舟山銀岱自高新技術企業證書頒發之日所在年度起的連續三個會計年度(即2021年度至2023年度)繼續享受高新技術企業的相關税收優惠政策,即按15%的税率繳納企業所得税。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.